Future Perspectives and Unmet Needs in Renal Cell Carcinoma
The expert panel provides key takeaways and closing thoughts on future perspectives and unmet needs in the treatment of renal cell carcinoma.
Source: onclive.com
Advanced Rcc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Advanced Rcc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Advanced Rcc Today - Breaking & Trending Today
Nivolumab Plus Cabozantinib in Non–Clear Cell RCC
David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.
Source: onclive.com
KEYNOTE-B61: Lenvatinib Plus Pembrolizumab in Non–Clear Cell RCC
Focusing on the KEYNOTE-B61 trial evaluating lenvatinib plus pembrolizumab in the first line, a panel of medical oncologists react to clinical trial data on combination regimens in non–clear cell renal cell carcinoma.
Source: onclive.com
Overview of Non–Clear Cell RCC
The expert panel gives an overview of non–clear cell renal cell carcinoma, highlighting disease subtypes and treatment approaches.
Source: onclive.com
Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC
Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.
Source: onclive.com